Company intelligence
Rose Pharma Inc.
Unlocking multi-billion dollar opportunity w novel GLP1 for weight loss maintenance & IBS pain relief. Seeking partners.
Pharmaceutical Manufacturing
Remote Locations, US
4 employees
1 public signals
About Rose Pharma Inc.
Rose Pharma, Inc. is a clinical-stage biopharmaceutical company developing a differentiated, short-acting GLP-1 designed to fill the critical market gap in weight loss maintenance, improved tolerability, and IBS pain reduction. With a multi-billion dollar market opportunity, our Phase 2b asset offers a high-value commercial potential in the rapidly expanding GLP-1 space. We are actively seeking corporate partnerships for development and commercialization of Rose10 in IBS pain and weight management.
Verified activity
Signals from Rose Pharma Inc.
1 published signal